The Market Reports

Synopsis
The global market for Pharma and Health Care was estimated to be worth US$ 1346750 million in 2024 and is forecast to a readjusted size of US$ 1765410 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments. Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician. In this report, we mainly study the pharma and healthcare product.
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%. Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.
This report aims to provide a comprehensive presentation of the global market for Pharma and Health Care, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharma and Health Care by region & country, by Format, and by Prescription.
The Pharma and Health Care market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma and Health Care.
Market Segmentation
By Company
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
Hengrui Medicine
Fosun Pharma
Shanghai Pharma
Sino Biopharmaceutical
Yunnan Baiyao
Segment by Format
Bottle
Blister
Others
Segment by Prescription
OTC Drugs
Prescription Drugs
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharma and Health Care company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Format, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Prescription, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pharma and Health Care in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pharma and Health Care in country level. It provides sigmate data by Format, and by Prescription for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index